Articles

Original Research

10.4244/EIJ-D-24-00619 Nov 18, 2024
Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants
Meier D, Nigade A, Lai A, Dorman K, Gill H, Javani S, Akodad M, Wood D, Rogers T, Puri R, Allen K, Chhatriwalla A, Reardon M, Tang G, Bapat V, Webb J, Fukuhara S, Sellers S

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G, Kobari Y, Khokhar A, Abdel-Wahab M, Abdelhafez A, Fukui M, Kofoed K, Dudek D, Fuchs A, Cavalcante J, Hayashida K, Tang G, Mylotte D, Bapat V, Backer O

Research Correspondence

10.4244/EIJ-D-24-00702 Nov 18, 2024
Redo-TAVI feasibility and coronary accessibility following index TAVI with the Evolut valve in patients with bicuspid aortic valve stenosis
Arslani K, Tirado-Conte G, Van Mieghem N, Mylotte D, Tang G, Bapat V, Leroux L, Tchétché D, Grubb K, De Backer O

Original Research

10.4244/EIJ-D-24-00490 Nov 18, 2024
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure
Andreas M, Kerbel T, Mach M, Zierer A, Kuhn E, Sauer J, Ruge H, Reguiero A, Colli A

Original Research

10.4244/EIJ-D-23-01092 Nov 18, 2024
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair
Ono S, Kubo S, Maruo T, Nishiura N, Mushiake K, Osakada K, Kadota K, Yamamoto M, Saji M, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yamaguchi J, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Otsuka T, Hayashida K, investigators O

Research Correspondence

10.4244/EIJ-D-24-00158 Nov 18, 2024
Temporal trends in characteristics of patients undergoing transcatheter tricuspid edge-to-edge repair for tricuspid regurgitation
Kresoja K, Stolz L, Schöber A, Rommel K, Rosch S, Schlotter F, Gerçek M, Pauschinger C, Rottbauer W, Kassar M, Goebel B, Denti P, Rassaf T, Barreiro-Perez M, Boekstegers P, Zdanyte M, Adamo M, Vincent F, Schlegel P, von Bardeleben R, Wild M, Toggweiler S, Konstandin M, Van Belle E, Metra M, Geisler T, Estevez-Loureiro R, Luedike P, Maisano F, Lauten P, Praz F, Keßler M, Rück A, Kalbacher D, Rudolph V, Iliadis C, Thiele H, Hausleiter J, Lurz P, EuroTR investigators obot

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Editorial

10.4244/EIJ-E-24-00053 Nov 4, 2024
The future of sirolimus-coated balloon use in percutaneous coronary intervention
Yeh R, Lalani C
free

Original Research

10.4244/EIJ-D-23-00868 Nov 4, 2024
A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions
Scheller B, Mangner N, Jeger R, Afan S, Mahfoud F, Woitek F, Fahrni G, Schwenke C, Schnorr B, Kleber F

Original Research

10.4244/EIJ-D-24-00362 Nov 4, 2024
Natural history of a newly developed calcified nodule: incidence, predictors, and clinical outcomes
Sugizaki Y, Matsumura M, Chen Y, Tsukui T, Shlofmitz E, Thomas S, Malik S, Dakroub A, Singh M, Shin D, Granville M, Busch J, Wolff E, Miraglia G, Moses J, Khalique O, Cohen D, Mintz G, Shlofmitz R, Jeremias A, Ali Z, Maehara A

Original Research

10.4244/EIJ-D-24-00491 Nov 4, 2024
Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry
De Filippo O, Wańha W, Sanavia T, Januszek R, Giacobbe F, Campo G, Pinxterhuis T, Capodanno D, Tomasiewicz B, Iannaccone M, Leone A, Wolny R, Bruno F, Patti G, Musumeci G, Liccardo G, Verardi R, Roubin S, Tarantini G, Kuzma L, Perl L, Gagnor A, Reczuch K, Conrotto F, Tuttolomondo D, Ploumen E, Niezgoda P, Caglioni S, Omedè P, Greco A, Kubica J, Gil R, Piccolo R, Kornowski R, Bil J, Morena A, Zocca P, Pennone M, Gasior M, Jaguszewski M, von Birgelen C, Fariselli P, De Ferrari G, Wojakowski W, D’ascenzo F

Trial Design

10.4244/EIJ-D-24-00437 Nov 4, 2024
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
Park H, Kang D, Ahn J, Yun S-C, Park K, Kang S, Suh J, Bae J, Park S, Cho JH, Suh J, Lee B, Rha S, Won H, Jang J, Kim MH, Lee CH, Ahn YK, Oh J, Bae J, Park CS, Choi J, Lee J, Lee S, Hur S, Kwon O, Park S, Park D

Original Research

10.4244/EIJ-D-24-00240 Oct 21, 2024
Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trial
Bangalore S, Rhodes G, Maron D, Anthopolos R, O’Brien S, Jones P, Mark D, Reynolds H, Spertus J, Stone G, White H, Xu Y, Fremes S, Hochman J, obotIRG
Receive our newsletter


PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved